Gamble Jones Investment Counsel Novartis Ag Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Novartis Ag stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 143,327 shares of NVS stock, worth $14.9 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

143,327

Previous 145,389 1.42%

Holding current value

$14.9 Million

Previous $11.1 Million 17.65%

% of portfolio

0.98%

Previous 0.9%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $155,784 - $190,776	-2,062 Reduced 1.42%	143,327 $13 Million
Q3 2022 Nov 03, 2022	BUY	$74.61 - $87.26 $50,287 - $58,813	674 Added 0.47%	145,389 $11.1 Million
Q2 2022 Aug 05, 2022	SELL	$80.52 - $93.75 $179,479 - $208,968	-2,229 Reduced 1.52%	144,715 $12.2 Million
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $77,065 - $87,176	-962 Reduced 0.65%	146,944 $12.9 Million
Q4 2021 Feb 09, 2022	BUY	$79.7 - $88.13 $50,928 - $56,315	639 Added 0.43%	147,906 $12.9 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $75,155 - $87,433	919 Added 0.63%	147,267 $12 Million
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $6,819 - $7,532	-80 Reduced 0.05%	146,348 $13.4 Million
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $233,633 - $275,519	2,798 Added 1.95%	146,428 $12.5 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $27,714 - $33,522	355 Added 0.25%	143,630 $13.6 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $123,538 - $136,864	-1,504 Reduced 1.04%	143,275 $12.5 Million
Q2 2020 Aug 19, 2020	SELL	$80.93 - $91.1 $93,716 - $105,493	-1,158 Reduced 0.79%	144,779 $12.6 Million
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $89,538 - $125,445	-1,267 Reduced 0.86%	145,937 $12 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $177,809 - $201,039	-2,108 Reduced 1.41%	147,204 $13.9 Million
Q3 2019 Nov 04, 2019	BUY	$85.54 - $94.26 $157,821 - $173,909	1,845 Added 1.25%	149,312 $13 Million
Q2 2019 Aug 20, 2019	BUY	$75.4 - $92.8 $75,324 - $92,707	999 Added 0.68%	147,467 $13.5 Million
Q1 2019 May 02, 2019	BUY	$75.32 - $86.15 $354,983 - $406,024	4,713 Added 3.32%	146,468 $14.1 Million
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $50,236 - $55,937	682 Added 0.48%	141,755 $12.2 Million
Q3 2018 Nov 06, 2018	BUY	$66.94 - $77.43 $504,459 - $583,512	7,536 Added 5.64%	141,073 $12.2 Million
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $118,525 - $133,955	1,826 Added 1.39%	133,537 $10.1 Million
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $1.33 Million - $1.59 Million	18,944 Added 16.8%	131,711 $10.6 Million
Q4 2017 Feb 06, 2018	BUY	$72.33 - $77.64 $12,657 - $13,587	175 Added 0.16%	112,767 $9.47 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $8.35 Million - $8.7 Million	112,592	112,592 $9.67 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Novartis Ag Transaction History